Furthermore, SFN displayed significant antioxidant and chemopreventive activities by inhibiting the IL-1β-induced expression of IL-6 and the subsequent MAPK/AP-1/STAT3 signaling in HT-29 colon cancer cells. The gene discussed is FOS; the disease is malignant colon neoplasm.